SCHEMBL21596776

SCHEMBL21596776

COCc1ccc2c(N)noc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
KAT7 O95251 2/20 0.39
KAT6A Q92794 2/20 0.39
MAOA P21397 1/20 0.37
DYRK1A Q13627 1/20 0.37
LTB4R Q15722 1/20 0.36
KLKB1 P03952 3/20 0.35
MAP4K1 Q92918 2/20 0.35
MASP2 O00187 1/20 0.35
F9 P00740 1/20 0.34
IDO1 P14902 2/20 0.34
MAPK14 Q16539 1/20 0.34
LCK P06239 1/20 0.33
CSF1R P07333 1/20 0.33
KAT6B Q8WYB5 1/20 0.33
KAT5 Q92993 1/20 0.33
KAT8 Q9H7Z6 1/20 0.33
CA2 P00918 1/20 0.33
ESR1 P03372 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12012754 0.81 NOS3 (0.39) LMNATP53KLKB1MAP4K1MASP2
SCHEMBL3890977 0.80 ROCK1 (0.46) KLKB1MAP4K1MASP2F9IDO1
SCHEMBL28579520 0.79 KLKB1 (0.37) LTB4RKLKB1MAP4K1MASP2IDO1
Hydrochloric Acid SCHEMBL23201164 0.78 ROCK1 (0.45) KLKB1MAP4K1MASP2F9IDO1
SCHEMBL13486443 0.77 IKBKE (0.43) DYRK1ALTB4RKLKB1MAP4K1MASP2
SCHEMBL7534371 0.77 ROCK1 (0.41) LTB4RKLKB1MAP4K1MASP2F9
SCHEMBL6931962 0.77 TEC (0.50) MAOA
Methylsulfanylmethane SCHEMBL7534377 0.76 ROCK1 (0.41) LTB4RKLKB1MAP4K1MASP2F9
SCHEMBL6957651 0.75 LTB4R (0.47) LTB4RF9
SCHEMBL16059525 0.75 CYP2D6 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260062393-A1 Compounds CTXT PTY LTD (AU) 2026-03-05 US disclosed
US-12365655-B2 Compounds CTXT PTY LTD (AU) 2025-07-22 US disclosed
CN-112334466-B Compounds of formula (I) CTXT私人有限公司 2025-05-30 CN disclosed
EP-4335439-A2 COMPOUNDS CTXT PTY LTD (AU) 2024-03-13 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
EP-3810602-B1 COMPOUNDS CTXT PTY LTD (AU) 2023-11-01 EP disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
US-20220153710-A1 Compounds CTXT PTY LTD (AU) 2022-05-19 US disclosed
EP-3810602-A1 COMPOUNDS CTXT Pty Limited (AU) 2021-04-28 EP disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
US-20200039945-A1 Compounds CTXT PTY LIMITED (AU) 2020-02-06 US disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed
WO-2019243491-A1 COMPOUNDS CTXT PTY LIMITED (AU) 2019-12-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153710-A1 Compounds SLC10A1, ABCB11, PCSK9 LMNA 1393/4885TP53 3501/4885KAT7 490/4885
US-20200039945-A1 Compounds SLC10A1, ABCB11, PCSK9 LMNA 1392/4885TP53 3504/4885KAT7 490/4885
US-20260062393-A1 Compounds SCN2B, ABCB11, SCN1B LMNA 3274/4885TP53 4584/4885KAT7 271/4885
US-12365655-B2 Compounds SLC10A1, ABCB11, PCSK9 LMNA 1392/4885TP53 3504/4885KAT7 490/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.